Novo Nordisk, headquartered in Denmark, is a global leader in the pharmaceutical industry, dedicated to developing innovative therapeutic solutions for individuals with chronic conditions. Our commitment to research and innovation drives our mission to enhance the lives and well-being of those affected by diabetes, obesity, hemophilia, and rare endocrine disorders. With a presence in over 169 countries, we operate worldwide and employ more than 65,000 professionals across 80 offices. In Italy, Novo Nordisk S.p.A. is situated in Rome, at Viale Giorgio Ribotta 35.